TY  - GEN
AU  - el-Sadr,W M
AU  - Perlman,D C
AU  - Matts,J P
AU  - Nelson,E T
AU  - Cohn,D L
AU  - Salomon,N
AU  - Olibrice,M
AU  - Medard,F
AU  - Chirgwin,K D
AU  - Mildvan,D
AU  - Jones,B E
AU  - Telzak,E E
AU  - Klein,O
AU  - Heifets,L
AU  - Hafner,R
TI  - Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG)
SN  - 1058-4838
PY  - 1998///0716
KW  - AIDS-Related Opportunistic Infections
KW  - drug therapy
KW  - Adult
KW  - Antitubercular Agents
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Ethambutol
KW  - Female
KW  - Humans
KW  - Isoniazid
KW  - Levofloxacin
KW  - Male
KW  - Microbial Sensitivity Tests
KW  - Mycobacterium tuberculosis
KW  - drug effects
KW  - Ofloxacin
KW  - Pyrazinamide
KW  - Recurrence
KW  - Rifampin
KW  - Sputum
KW  - microbiology
KW  - Treatment Outcome
KW  - Tuberculosis, Pulmonary
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1086/520275
ER  -